SCHEMBL1606580

SCHEMBL1606580

CCC(=O)c1cccc(O)c1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 1/20 0.55
TERT O14746 2/20 0.50
ALOX5 P09917 1/20 0.50
IAPP P10997 5/20 0.49
POLB P06746 1/20 0.46
ALDH1A1 P00352 3/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
ADAMTS4 O75173 1/20 0.44
EGFR P00533 1/20 0.44
LMNA P02545 1/20 0.44
FYN P06241 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
MMP8 P22894 1/20 0.44
CA6 P23280 1/20 0.44
CDK2 P24941 1/20 0.44
MMP12 P39900 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2986601 0.85 HSP90AB1 (0.57) HSP90AB1POLBALDH1A1HPGDALOX15
SCHEMBL29383556 0.83 HSP90AB1 (0.59) HSP90AB1POLBALDH1A1CA1CA2
SCHEMBL111675 0.83 HSP90AB1 (0.59) HSP90AB1POLBALDH1A1CA1CA2
SCHEMBL4116876 0.82 ALDH1A1 (0.62) HSP90AB1ALDH1A1HPGDHSD17B10MAPT
SCHEMBL10878661 0.82 CA9 (0.50) HSP90AB1POLBALDH1A1CA1CA2
SCHEMBL11651879 0.82 KDM4E (0.47) HSP90AB1ALDH1A1LMNAHPGDHSD17B10
SCHEMBL671234 0.82 HSP90AB1 (0.48) HSP90AB1IAPPPOLBALDH1A1CA1
SCHEMBL2763225 0.82 ALDH1A1 (0.57) HSP90AB1ALDH1A1CA1CA2LMNA
Methane SCHEMBL28748613 0.81 HSP90AB1 (0.57) HSP90AB1POLBALDH1A1CA1CA2
SCHEMBL1878649 0.81 TERT (0.52) TERTALOX5IAPPALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113485072-B Photoresist composition and application thereof 北京科华微电子材料有限公司 2023-11-07 CN claimed
CN-114031736-B Modified phenolic resin for photoresist, preparation method thereof and photoresist composition 广东粤港澳大湾区黄埔材料研究院 2023-10-10 CN claimed
CN-114031736-A Modified phenolic resin for photoresist, preparation method thereof and photoresist composition 广东粤港澳大湾区黄埔材料研究院 2022-02-11 CN claimed
CN-113485072-A Photoresist composition and application thereof 北京科华微电子材料有限公司 2021-10-08 CN claimed
CN-101405321-A Heat Curable Epoxy-Amine Barrier Sealants NAT STARCH CHEM INVEST (US) 2009-04-08 CN claimed
US-20080255228-A1 Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles BIODERM RESEARCH (US) 2008-10-16 US claimed
US-20080254130-A1 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction BIODERM RESEARCH (US) 2008-10-16 US claimed
US-7427690-B2 Multifunction “crown complexes” from amino acids and peptides for skin and hair restoration BIODERM RESEARCH (US) 2008-09-23 US claimed
CN-101182318-A Method for preparing dimefline hydrochloride SHANGHAI ZIYUAN PHARMACEUTICAL (CN) 2008-05-21 CN claimed
US-20070099886-A1 Multifunction \"Crown Complexes\" from Amino Acids and Peptides for Skin and Hair Restoration BIODERM RESEARCH (US) 2007-05-03 US claimed
US-20060074108-A1 Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition BIODERM RESEARCH (US) 2006-04-06 US claimed
US-20050271608-A1 Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives GUPTA SHYAM K 2005-12-08 US claimed
EP-0192492-B1 PEPTIDES CONTAINING AN ALIPHATIC-AROMATIC KETONE SIDE CHAIN THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1992-01-02 EP claimed
EP-4554549-A1 COMPOSITION COMPRISING SKIN CARE ACTIVE INGREDIENT OR CELLULOSE COMPOUND L'OREAL (FR) 2025-05-21 EP disclosed
EP-4452205-A1 COMPOSITION COMPRISING SOLUBILIZED POLYPHENOL L'OREAL (FR) 2024-10-30 EP disclosed
WO-2024014310-A1 COMPOSITION COMPRISING SKIN CARE ACTIVE INGREDIENT OR CELLULOSE COMPOUND L'OREAL (FR) 2024-01-18 WO disclosed
CN-1035118-A A kind of method that forms polymer-scale that stops SHINETSU CHEMICAL CO (JP) 1989-08-30 CN disclosed
EP-0320227-A2 Method of preventing polymer-scale formation Shin-Etsu Chemical Co., Ltd. (JP) 1989-06-14 EP disclosed
US-4677193-A GONADOTROPIN-RELEASING FACTOR ANALOGS THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1987-06-30 US disclosed
EP-0192492-A2 Peptides containing an aliphatic-aromatic ketone side chain THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1986-08-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080254130-A1 Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction PSMB1, PLOD3, CUTA HSP90AB1 677/4885TERT 880/4885ALOX5 491/4885
US-20080255228-A1 Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles PROC, COL1A1, CUTA HSP90AB1 1306/4885TERT 468/4885ALOX5 344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.